Mounjaro®
Starting from £179.99/mo
Start journey Learn moreAches and pains are among the less-talked-about side effects of tirzepatide, yet plenty of people starting Mounjaro notice them, particularly in the first few weeks of treatment. They are generally mild, often short-lived, and tend to ease as the body adjusts — but knowing why they happen and which warning signs to watch for makes a real difference to how you manage them. These are prescription-only medicines assessed by a GPhC-registered prescriber, and your individual experience is always worth discussing with your clinical team. The NHS's tirzepatide medicines page lists the full recognised side-effect profile, which includes musculoskeletal discomfort alongside the more commonly reported gastrointestinal symptoms.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
That precise complaint (a low-grade, slightly baffling achiness with no obvious cause) is something a fair number of people on tirzepatide describe in the early weeks. It does not mean the medicine is harming you, and it does not mean you have done anything wrong. What it usually means is that your body is responding to a significant change: appetite is falling, food intake is lower, and your system is recalibrating.
There are a few plausible mechanisms at play. Tirzepatide slows gastric emptying and reduces appetite markedly, particularly at the beginning. If you are eating and drinking considerably less than usual, mild dehydration follows quietly, and dehydration is a well-established driver of muscle cramps and general achiness. Separately, reduced calorie intake means less fuel arriving at muscles; some people notice fatigue-like heaviness rather than classical pain. The body also responds to novel hormonal signals from a dual GIP and GLP-1 receptor agonist (a category with no direct predecessor in UK weight-loss prescribing) and that adjustment period matters.
If you would like to understand more about why Mounjaro causes body aches specifically, the picture is explored in more detail there. For now, the reassuring pattern is that these sensations are usually transient: they tend to peak in the first week or two after starting a new dose, then fade. Many people report they do not return at subsequent dose steps.
Tirzepatide is titrated gradually, starting at 2.5 mg and typically increasing in four-week steps under prescriber oversight. Each step can bring a short recurrence of early side effects, nausea, fatigue and achiness among them. This is not a sign the new dose is wrong; it mirrors what happened when treatment first began, and for most people it resolves on the same timescale.
The dehydration angle is worth revisiting here too. Nausea is often stronger at each new dose increment, which means fluid intake can dip again without the person noticing. A practical measure that many prescribers recommend: consciously increase water intake in the two weeks after any dose step, even if thirst does not prompt it. Small, regular sips across the day tend to work better than large amounts at once when the stomach is sensitive.
Spreading the physical context further, muscle aches on tirzepatide can sometimes be distinguished from general body soreness by their location and character. If the discomfort is specifically concentrated in muscles rather than joints, feels like post-exercise stiffness, and eases with gentle movement, it is unlikely to be anything requiring urgent attention.
The private cost of treatment is one thing people weigh up when deciding whether to continue through an uncomfortable patch. Our guide to Mounjaro costs in the UK sets out what the market looks like, including what a legitimate price typically includes beyond the pen itself. That context can help you judge whether what you are paying elsewhere is reasonable, or whether a very low price is a warning sign.
Most aches on tirzepatide are nuisance-level and self-resolving. A minority are signals you should not sit with.
In January 2026 the MHRA issued a Drug Safety Update on GLP-1 medicines, specifically highlighting acute pancreatitis as a known but infrequent side effect that can be serious. The symptom to recognise: severe, persistent pain in the upper abdomen that may travel through to the back, sometimes accompanied by vomiting. This is not the same as ordinary nausea or a vague tummy ache. If you experience that pattern, stop what you are doing and get medical help promptly rather than waiting to see if it passes.
Other pain patterns that warrant a call to your GP or prescriber rather than home management include pain that is worsening rather than settling across the first two weeks, pain accompanied by fever, any new pain in the right side of your abdomen (which can point to gallbladder changes, another recognised GLP-1 association), and any musculoskeletal pain so significant it is affecting your ability to move normally.
If you are uncertain whether your experience fits a normal adjustment pattern or something that needs assessment, the question our prescribers hear regularly is essentially: is this expected or is it something else? That is exactly the kind of thing to raise. People who want to explore whether Mounjaro is the direct cause of their aching sometimes find it useful to map the timing carefully, did it start within days of a dose change? That temporal link is usually informative.
A few straightforward measures reduce how pronounced aches feel during the adjustment window. Staying well-hydrated is the most consistently reported one, not just the standard eight glasses framing, but being deliberate about it when appetite and thirst are both suppressed. Gentle movement helps too: long periods of stillness tend to make musculoskeletal discomfort feel worse, and light walking or stretching keeps things from stiffening.
Protein intake deserves attention. When total calories fall sharply, it is easy to eat too little protein; muscle soreness can be amplified when the body is drawing on muscle for energy. A prescriber or dietitian can advise on appropriate targets, but as a general principle, making protein the priority in smaller meals tends to help body composition and comfort during treatment.
Over-the-counter pain relief is used by some people for short-term ache management, but the right choice depends on your medical history, and our page covering Mounjaro aches and pains includes guidance on what to consider before reaching for anything from the medicine cabinet. Always check with a pharmacist or your prescriber before adding anything new.
If you are wondering whether Mounjaro is specifically what's making you ache, or whether something else is contributing, that distinction is worth making with clinical input rather than guesswork. Our prescribers are available seven days a week. If this is a good point to check whether tirzepatide is right for you (or to review how your current treatment is going) you can speak to our prescribers through a free consultation. One more thing worth knowing: if you are planning to order around a bank holiday or your usual Monday is disrupted, the 12pm cut-off for same-day dispatch still applies on working days, so a Tuesday order after a long weekend goes through the same clinical review process with the same tracked delivery promise.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.